Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effects of low-dose TRH on cognitive deficits in the ECT postictal state.

Khan A, Mirolo MH, Claypoole K, Bhang J, Cox G, Horita A, Tucker G.

Am J Psychiatry. 1994 Nov;151(11):1694-6.

PMID:
7943463
2.

Effects of thyrotropin-releasing hormone administration on the electroconvulsive therapy induced prolactin responses and seizure time.

Papakostas Y, Markianos M, Pehlivanidis A, Papadimitriou GN, Zervas IM, Daras M, Stefanis C.

Biol Psychiatry. 1996 Mar 15;39(6):444-7.

PMID:
8679790
3.

ECT and TRH: cholinergic involvement in a cognitive deficit state.

Khan A, Mirolo MH, Lai H, Claypoole K, Bierut L, Malik R, Bhang J.

Psychopharmacol Bull. 1993;29(3):345-52.

PMID:
8121962
4.

Effects of TRH administration on orientation time and recall after ECT.

Zervas IM, Pehlivanidis AA, Papakostas YG, Markianos M, Papadimitriou GN, Stefanis CN.

J ECT. 1998 Dec;14(4):236-40.

PMID:
9871843
5.

Double-blind placebo controlled study of the effects of etomidate-alfentanil anesthesia in electroconvulsive therapy.

van den Broek WW, Groenland TH, Kusuma A, Mulder PG, Bruijn JA.

J ECT. 2004 Jun;20(2):107-11.

PMID:
15167427
6.

Nicardipine improves the antidepressant action of ECT but does not improve cognition.

Dubovsky SL, Buzan R, Thomas M, Kassner C, Cullum CM.

J ECT. 2001 Mar;17(1):3-10.

PMID:
11281512
7.

Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects.

Perera TD, Luber B, Nobler MS, Prudic J, Anderson C, Sackeim HA.

Neuropsychopharmacology. 2004 Apr;29(4):813-25.

9.

Propofol reduces cognitive impairment after electroconvulsive therapy.

Butterfield NN, Graf P, Macleod BA, Ries CR, Zis AP.

J ECT. 2004 Mar;20(1):3-9.

PMID:
15087989
10.

Low-dose thyrotropin-releasing hormone effects in cognitively impaired alcoholics.

Khan A, Mirolo MH, Claypoole K, Hughes D.

Alcohol Clin Exp Res. 1993 Aug;17(4):791-6.

PMID:
8214416
11.

Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.

Mellow AM, Sunderland T, Cohen RM, Lawlor BA, Hill JL, Newhouse PA, Cohen MR, Murphy DL.

Psychopharmacology (Berl). 1989;98(3):403-7.

PMID:
2501817
12.

Thyrotropin-releasing hormone administration does not affect seizure threshold during electroconvulsive therapy.

Zervas IM, Papakostas YG, Theodoropoulou MA, Dimitrakopoulos C, Vaidakis N, Daras M.

J ECT. 2003 Sep;19(3):136-8.

PMID:
12972982
13.

Blunted TSH response to TRH and seizure duration in ECT.

Papakostas YG, Markianos M, Pehlivanidis A, Zervas IM, Papadimitriou GN, Stefanis C.

Acta Psychiatr Scand. 1999 Jan;99(1):68-72.

PMID:
10066009
14.

Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial.

Loo CK, Katalinic N, Garfield JB, Sainsbury K, Hadzi-Pavlovic D, Mac-Pherson R.

J Affect Disord. 2012 Dec 15;142(1-3):233-40. doi: 10.1016/j.jad.2012.04.032. Epub 2012 Aug 2.

PMID:
22858219
15.

Prolactin response induced by ECT and TRH.

Papakostas Y, Markianos M, Papadimitriou G, Stefanis C.

Br J Psychiatry. 1986 Jun;148:721-3.

PMID:
3096413
16.

Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study.

Prudic J, Fitzsimons L, Nobler MS, Sackeim HA.

Neuropsychopharmacology. 1999 Aug;21(2):285-93.

17.

Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression.

Krog-Meyer I, Kirkegaard C, Kijne B, Lumholtz B, Smith E, Lykke-Olesen L, Bjørum N.

Am J Psychiatry. 1984 Aug;141(8):945-8.

PMID:
6431834
18.

Thyrotropin-releasing hormone: differential antidepressant and endocrinological effects.

Furlong FW, Brown GM, Beeching MF.

Am J Psychiatry. 1976 Oct;133(10):1187-90.

PMID:
823828
19.

Thyrotropin-releasing hormone (TRH) inchronic schizophrenia. A controlled study.

Lindström LH, Gunne LM, Ost LG, Persson E.

Acta Psychiatr Scand. 1977 Jan;55(1):74-80.

PMID:
402794
20.

Propofol interruption of ECT seizure to reduce side-effects: a pilot study.

Warnell RL, Swartz CM, Thomson A.

Psychiatry Res. 2010 Jan 30;175(1-2):184-5. doi: 10.1016/j.psychres.2009.08.019. Epub 2009 Nov 5.

PMID:
19892408
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk